• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Seven U.K. research councils collaborate on antimicrobial resistance

Seven U.K. research councils collaborate on antimicrobial resistance

July 17, 2014
CenterWatch Staff

The Medical Research Council (MRC) will lead an initiative of seven research councils, backed by eight government bodies and the Wellcome Trust, to tackle antimicrobial resistance (AMR) on all fronts. The seven research councils are the Arts and Humanities Research Council, Biotechnology and Biological Sciences Research Council, Economic and Social Research Council, Engineering and Physical Sciences Research Council, MRC, Natural Environment Research Council and Science and Technology Facilities Council.

The seven will collaborate on the ever-growing problem of antimicrobial resistance. The cross-council AMR initiative will coordinate the work of medical researchers, biologists, engineers, vets, economists, social scientists, mathematicians and designers in a multi-pronged approach to address all aspects of the multi-faceted problem.

The MRC has calculated in the U.K. alone, $470 million has been spent on researching the problem since 2007. Yet, to date, no effective solutions have been found and it has been estimated that current antibiotics will be all but useless within the next two decades. A recent Science and Technology Committee report on antimicrobials stated collaboration among different areas of research is paramount in tackling AMR.

The problem of AMR extends beyond human health. Animals, particularly livestock, are increasingly being infected with antibiotic-resistant bacteria. Such bacteria are found in varied environments, from fields and rivers to hospitals or the kitchen sink, but little is known about how human and animal AMR are related. The initiative will work to identify common characteristics of AMR in both humans and in farm and wild animals in order to find new drugs in a pipeline that has all but dried up.

At the same time, scientists will be investigating how to track the extent of AMR in different environments (the sea, rivers, air, soil and in organisms, as well as in food, homes and hospitals.) Researchers funded by the Natural Environment Research Council have revealed the first finding of an imipenam-resistant E. coli in a U.K. river, a broad spectrum antibiotic that’s often used when other antibiotics don’t work.

Science Minister Greg Clark said, “This unique collaboration involving all seven research councils will help to drive forward important advances in the fight against antimicrobial resistance. The united strategy will provide a more coordinated approach to research gathering by bringing together leading cross-industry experts against what is one of today’s greatest scientific problems.”

Professor Sir John Savill, chief executive of the MRC, said, “Researchers have been waging a war on AMR for decades but up until now we’ve had no war cabinet to coordinate research on all fronts. This is about tackling the problem at every level and in every environment—from labs to livestock, from finding new diagnostic tools to educating professionals and the public. One hundred years ago, 25% of all deaths were due to bacterial infection. We cannot return to those days.”

Two calls for research proposals now are open. The deadline is Sept. 2.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing